SCIASCIA, Savino
SCIASCIA, Savino
SCIENZE CLINICHE E BIOLOGICHE
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
2014-01-01 Bertolaccini, Maria Laura; Amengual, Olga; Andreoli, Laura; Atsumi, Tatsuya; Chighizola, Cecilia B.; Forastiero, Ricardo; de Groot, Philip; Lakos, Gabriella; Lambert, Marc; Meroni, Pierluigi; Ortel, Thomas L.; Petri, Michelle; Rahman, Anisur; Roubey, Robert; Sciascia, Savino; Snyder, Melissa; Tebo, Anne E.; Tincani, Angela; Willis, Rohan
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome
2021-01-01 Sciascia S.; Radin M.; Cecchi I.; Levy R.A.; Erkan D.
16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome
2020-01-01 de Jesus G.R.; Benson A.E.; Chighizola C.B.; Sciascia S.; Branch D.W.
A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response
2021-01-01 Rossi, Daniela; Sciascia, Savino; Cecchi, Irene; Saracco, Marta; Montabone, Erika; Modena, Vittorio; Pellerito, Raffaele; Carignola, Renato; Roccatello, Dario
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy.
2012-01-01 Roccatello, D; Sciascia, S; Baldovino, S; Rossi, D
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
2017-01-01 Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment
2015-01-01 Roccatello, Dario; Sciascia, Savino; Baldovino, Simone; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Di Simone, Debora; Simoncini, Matteo; Menegatti, Elisa
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study.
2012-01-01 Sciascia S; Roccatello D; Bertero MT; Di Simone D; Cosseddu D; Vaccarino A; Bazzan M; Rossi D; Garcia-Fernandez C; Ceberio L; Stella S; Menegatti E; Baldovino S.
Acute kidney injury associated with glomerular diseases
2019-01-01 Fenoglio R.; Sciascia S.; Baldovino S.; Roccatello D.
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
2019-01-01 Radin M.; Sciascia S.; Erkan D.; Pengo V.; Tektonidou M.G.; Ugarte A.; Meroni P.; Ji L.; Belmont H.M.; Cohen H.; Ramires de Jesus G.; Branch D.W.; Fortin P.R.; Andreoli L.; Petri M.; Rodriguez E.; Rodriguez-Pinto I.; Knight J.S.; Atsumi T.; Willis R.; Gonzalez E.; Lopez-Pedrera R.; Rossi Gandara A.P.; Borges Gualhardo Vendramini M.; Banzato A.; Sevim E.; Barbhaiya M.; Efthymiou M.; Mackie I.; Bertolaccini M.L.; Andrade D.
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction
2017-01-01 Radin, Massimo; Schreiber, K.; Costanzo, P.; Cecchi, I.; Roccatello, Dario; Baldovino, Simone; Bazzan, M.; Cuadrado, M. J.; Sciascia, Savino
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis
2021-01-01 Rossi, Daniela; Cecchi, Irene; Sciascia, Savino; Naretto, Carla; Alpa, Mirella; Roccatello, Dario
Air Pollution from Global Health to Individual Risk Factor-Is It Time for Enviropathies in Everyday Clinical Practice?
2022-01-01 Sciascia, Savino; Gilcrease, Gregory Winston; Roccatello, Lorenzo; Padovan, Dario; Peano, Cristiana; Ricceri, Fulvio
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients
2009-01-01 Heffler, E; Asero, R; Nebiolo, F; Pizzimenti, S; Sciascia, S; Badiu, I; Guida, G; Mistrello, G; Amato, S; Marchese, C; Rolla, G
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis
2020-01-01 Sciascia S.; Radin M.; Cecchi I.; Fenoglio R.; De Marchi A.; Besso L.; Baldovino S.; Rossi D.; Miraglia P.; Rubini E.; Roccatello D.
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
2013-01-01 Sciascia S;Sanna G;Murru V;Roccatello D;Khamashta MA;Bertolaccini ML
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
2020-01-01 Trunfio mattia, Salvador elena, Cabodi daniela, Marinaro Letizia, Alcantarini chiara, Gaviraghi Alberto, Trentalange Alice, Lipani Filippo, Sciascia Savino, Roccatello Dario, Bonora Stefano, Di Perri Giovanni, Calcagno Andrea
Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome
2014-01-01 Sciascia, S.; Bertolaccini, M.L.
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab
2018-01-01 Sciascia, Savino*; Rubini, Elena; Radin, Massimo; Cecchi, Irene; Rossi, Daniela; Roccatello, Dario
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study
2019-01-01 Sciascia, Savino; Yazdany, Jinoos; Dall'Era, Maria; Fenoglio, Roberta; Radin, Massimo; Aggarwal, Ishita; Cuadrado, Maria J.; Schreiber, Karen; Barreca, Antonella; Papotti, Mauro; Roccatello, Dario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends | 2014 | Bertolaccini, Maria Laura; Amengual, Olga; Andreoli, Laura; Atsumi, Tatsuya; Chighizola, Cecilia B.; Forastiero, Ricardo; de Groot, Philip; Lakos, Gabriella; Lambert, Marc; Meroni, Pierluigi; Ortel, Thomas L.; Petri, Michelle; Rahman, Anisur; Roubey, Robert; Sciascia, Savino; Snyder, Melissa; Tebo, Anne E.; Tincani, Angela; Willis, Rohan | |
| 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome | 2021 | Sciascia S.; Radin M.; Cecchi I.; Levy R.A.; Erkan D. | |
| 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome | 2020 | de Jesus G.R.; Benson A.E.; Chighizola C.B.; Sciascia S.; Branch D.W. | |
| A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response | 2021 | Rossi, Daniela; Sciascia, Savino; Cecchi, Irene; Saracco, Marta; Montabone, Erika; Modena, Vittorio; Pellerito, Raffaele; Carignola, Renato; Roccatello, Dario | |
| A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. | 2012 | Roccatello, D; Sciascia, S; Baldovino, S; Rossi, D | |
| The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study | 2017 | Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa | |
| A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment | 2015 | Roccatello, Dario; Sciascia, Savino; Baldovino, Simone; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Di Simone, Debora; Simoncini, Matteo; Menegatti, Elisa | |
| 8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. | 2012 | Sciascia S; Roccatello D; Bertero MT; Di Simone D; Cosseddu D; Vaccarino A; Bazzan M; Rossi D; Garcia-Fernandez C; Ceberio L; Stella S; Menegatti E; Baldovino S. | |
| Acute kidney injury associated with glomerular diseases | 2019 | Fenoglio R.; Sciascia S.; Baldovino S.; Roccatello D. | |
| The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort | 2019 | Radin M.; Sciascia S.; Erkan D.; Pengo V.; Tektonidou M.G.; Ugarte A.; Meroni P.; Ji L.; Belmont H.M.; Cohen H.; Ramires de Jesus G.; Branch D.W.; Fortin P.R.; Andreoli L.; Petri M.; Rodriguez E.; Rodriguez-Pinto I.; Knight J.S.; Atsumi T.; Willis R.; Gonzalez E.; Lopez-Pedrera R.; Rossi Gandara A.P.; Borges Gualhardo Vendramini M.; Banzato A.; Sevim E.; Barbhaiya M.; Efthymiou M.; Mackie I.; Bertolaccini M.L.; Andrade D. | |
| The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction | 2017 | Radin, Massimo; Schreiber, K.; Costanzo, P.; Cecchi, I.; Roccatello, Dario; Baldovino, Simone; Bazzan, M.; Cuadrado, M. J.; Sciascia, Savino | |
| An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis | 2021 | Rossi, Daniela; Cecchi, Irene; Sciascia, Savino; Naretto, Carla; Alpa, Mirella; Roccatello, Dario | |
| Air Pollution from Global Health to Individual Risk Factor-Is It Time for Enviropathies in Everyday Clinical Practice? | 2022 | Sciascia, Savino; Gilcrease, Gregory Winston; Roccatello, Lorenzo; Padovan, Dario; Peano, Cristiana; Ricceri, Fulvio | |
| Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients | 2009 | Heffler, E; Asero, R; Nebiolo, F; Pizzimenti, S; Sciascia, S; Badiu, I; Guida, G; Mistrello, G; Amato, S; Marchese, C; Rolla, G | |
| Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis | 2020 | Sciascia S.; Radin M.; Cecchi I.; Fenoglio R.; De Marchi A.; Besso L.; Baldovino S.; Rossi D.; Miraglia P.; Rubini E.; Roccatello D. | |
| Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. | 2013 | Sciascia S;Sanna G;Murru V;Roccatello D;Khamashta MA;Bertolaccini ML | |
| Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection | 2020 | Trunfio mattia, Salvador elena, Cabodi daniela, Marinaro Letizia, Alcantarini chiara, Gaviraghi Alberto, Trentalange Alice, Lipani Filippo, Sciascia Savino, Roccatello Dario, Bonora Stefano, Di Perri Giovanni, Calcagno Andrea | |
| Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome | 2014 | Sciascia, S.; Bertolaccini, M.L. | |
| Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab | 2018 | Sciascia, Savino*; Rubini, Elena; Radin, Massimo; Cecchi, Irene; Rossi, Daniela; Roccatello, Dario | |
| Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study | 2019 | Sciascia, Savino; Yazdany, Jinoos; Dall'Era, Maria; Fenoglio, Roberta; Radin, Massimo; Aggarwal, Ishita; Cuadrado, Maria J.; Schreiber, Karen; Barreca, Antonella; Papotti, Mauro; Roccatello, Dario |